×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
LS03: 5 Industry Group Joint Session:New Options in Clinical Trial Operation Model?DCT & Remote Utilization (Part 1)
Session Chair(s)
Hiroshi Matsuzawa, MSc
Clinical Development
Astellas Pharma Inc., Japan
Toshiharu Sano, RPh
Associate Vice President, Head of Clinical Operation Area
MSD K.K., Japan
Speaker(s)
Ai Nakamura
R&D Head Club, Japan
Performance Working Group Member
Takeshi Hashimoto, MPharm
Novartis Pharma K.K., Japan
Co-leader
Masahito Yamanaka
EFPIA (Bayer Yakuhin, Ltd.), Japan
Taskforce Member
Junichi Tanokashira
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Clinical Evaluation Expert Committee, Drug Evaluation Committee